ESPD2018 PROGRAMME
Pre-Conference Paediatric Dermatology Course for Trainees
In addition to the main programme there is a pre-meeting session running from 09:00 – 12:50 and includes 10 talks. The course is aimed at trainees and general practitioners with an interest Pediatric Dermatology.
09:00: - 12:50 Thursday 7th June
Costs:
£120 Rate
Please sign up via the main registration site. This course can be booked independently of the main meeting.
Programme:
| Time | Course |
|---|---|
| 08.55 – 09.00 | Introduction, Dr Karolina Gholam |
| 09.00 – 09.20 | Vascular Malformations, Dr Mary Glover |
| 09.20 – 09.40 | Vascular Tumours, Dr Samira Syed |
| 09.40 – 10.00 | Ichthyosis, Dr Anna Martinez |
| 10.00 – 10.20 | Congenital Melanocytic Naevi , Dr Maanasa Polubothu |
| 10.20 – 10.40 | Fever and Rashes, Dr Nerys Roberts |
| 10.40 – 11.10 | Break |
| 11.10 – 11.30 | Psoriasis, Dr Karolina Gholam |
| 11.30 – 11.50 | Eczema, Dr Lea Šolman |
| 11.50 – 12.10 | Neonatal dermatosis, Dr Lindsay Shaw |
| 12.10 – 12.30 | Blistering diseases, Dr Jemma Mellerio |
| 12.30 – 12.50 | Lumps and Bumps, Dr Cameron Kennedy |
THURSDAY 7 JUNE 2018
FLEMING AUDITORIUM
14:00 - 14:40 Opening Welcome & Keynote Lecture 01
14:00 - 14:05 Welcome Professor Regina Fölster-Holst (ESPD President) and Dr Veronica Kinsler (ESPD2018 President)
14:05 - 14:40 KL01 Neurofibromatosis type 1 and related conditions Eric Legius (Belgium)
FLEMING AUDITORIUM
14:50 - 15:50 Session 1 Epidermolysis Bullosa/Skin Fragility
Chairs: Anna Martinez (UK) & Neil Rajan (UK)
14:50 - 15:10 IL1.1 EB - The Basics - Anna Martinez (UK)
15:10 - 15:25 IL1.2 Research and New Therapies - John McGrath (UK)
15:25 - 15:40 IL1.3 How to Deep Phenotype EB - Marcel Jonkman (The Netherlands)
15:40 - 15:50 SP1.1 Results from the phase 3, randomized, double-blind, vehicle-controlled ESSENCE trial of the topical investigational drug SD-101 in patients with epidermolysis bullosa: Overall results and key subgroup analyses - Dr Cezary Kowalewski (Poland)
15:50 - 16:20 Coffee break, Posters, Exhibition (Britten & Pickwick rooms)
16:20 - 17:40 Session 3 Vascular Anomalies and Overgrowth
Chairs: Mary Glover (UK) & Henning Hamm (Germany)
16:20 - 16:35 IL3.1 Capillary Malformation and Overgrowth - Andrea Diociauti (Italy)
16:35 - 16:50 IL3.2 Lymphoedema in Children: What can we offer? - Annabel Maruani (France)
16:50 - 17:00 SP3.1 Low risk of embryonal cancer in PIK3CA-Related Overgrowth Spectrum: impact on screening recommendations - Mr Jean-Charles Crépin (France)
17:00 - 17:20 IL3.3 Sirolimus for vascular anomalies and overgrowth: When and how? - Mary Glover (UK)
17:20 - 17:40 IL3.4 How Genetic Knowledge Can Guide Medical Management of Vascular Anomalies - Miika Vikkula (Belgium)
WHITTLE AUDITORIUM
14:50 - 15:50 Session 2 Connective Tissue Diseases
Chairs: Nigel Burrows (UK) & Milos Nikolic (Serbia)
14:50 - 15:10 IL2.1 Inherited Disorders of Connective Tissue - Nigel Burrows (UK)
15:10 - 15:25 IL2.2 New Aspects in Localised Scleroderma (Morphoea) - Lisa Weibel (Switzerland)
15:25 - 15:40 IL2.3 Skin Signs of Inflammatory Disease - Lindsay Shaw (UK)
15:40 - 15:50 SP2.1 ANGIOKERATOMA-LIKE LESIONS ON LABIA MINORA: A NEW SIGN OFLICHEN SCLEROSUS IN CHILDREN? - Mr Andrea Bassi (Italy)
15:50 - 16:20 Coffee break, Posters, Exhibition (Britten & Pickwick rooms)
16:20 - 17:40 Session 4 Disorders of Keratinisation
Chairs: Vinzenz Oji (Germany) & Edel O’Toole
16:20 - 16:40 IL4.1 Update on Peeling Skin Diseases - Vinzenz Oji (Germany)
16:40 - 17:00 IL4.2 Update on the Palmoplantar Keratodermas - Edel O’Toole (UK)
17:00 - 17:20 IL4.3 Therapy of Ichthyoses: Disease Management Program and Patient Education - Juliette Mazereeuw Hautier (France)
17:20 - 17:30 SP4.1 Netherton Syndrome: A review of 15 Paediatric Patients - Cassie McDonald (UK)
17:30 - 17:40 SP4.2 Genotype-Phenotype Correlation in ARCI - An English Cohort - Dr Jacqueline Simpson (UK)
17:45 - 18:20 Keynote Lecture 02 KL02 What Have We Learned About Eczema From Routinely-Collected Data? Sinead Langan (UK)
Chairs: Barbara Binder (Austria) & Osman Köse (Turkey)
FLEMING AUDITORIUM
18:30 - 20:00 Welcome Reception (Britten Room)
FRIDAY 8 JUNE 2018
FLEMING AUDITORIUM
08:30 - 09:10 - UW Schnyder Memorial Lecture Prize 2018 - David Kelsell (UK)
09:15 - 10:15 Session 5 Genital Dermatology/Child Protection
Chairs: Karolina Gholam (UK) & Alberto Mota (Portugal)
09:15 - 09:35 IL5.1 Genital diseases in childhood - Karolina Gholam (UK)
09:35 - 09:55 IL5.2 When child abuse is a possibility: Key elements of forensic examination - Catherine White (UK)
09:55 - 10:15 IL5.3 Female Genital Mutilation-everybody’s business - Brenda Kelly (UK)
10:15 – 10:45 Coffee break, Posters, Exhibition
(Britten & Pickwick rooms)
WHITTLE AUDITORIUM
09:15 – 10:15 Session 6 Update on Laser/ Radiological/ Surgical Therapies
Chairs: Tess McPherson (UK) & Ayse Deniz Yucelten (Turkey)
09:15 – 09:35 IL6.1 Advanced IR management of Vascular Malformations - Alex Barnacle (UK)
09:35 – 09:55 IL6.2 Update on Laser Therapy for Children with Vascular Anomalies - Samira Syed (UK)
09:55 – 10:15 IL6.3 Neil Bulstrode (UK)
10:15 – 10:45 Coffee break, Posters, Exhibition
(Britten & Pickwick rooms)
10:45 – 11:20 Keynote Lecture 03 KL03 Ageing Disorders in Children Raoul Hennekam (The Netherlands)
Chairs: Slobodna Murat-Sušić (Croatia) & Ulrike Blume-Peytavi (Germany)
FLEMING AUDITORIUM
FLEMING AUDITORIUM
11:30 - 12:50 Session 7 Naevi and Other Mosaics
Chairs: Veronica Kinsler (UK) & Peter Steijlen (The Netherlands)
11:30 - 11:50 IL7.1 New (and useful) classification of CMN based on embryological insights - Veronica Kinsler (UK)
11:50 - 12:10 IL7.2 Blaschko-linear hypo- and hyper pigmentation - Pierre Vabres (France)
12:10 - 12:25 IL7.3 Novel aspects of epidermal mosaicism - Keith Choate (USA)
12:25 - 12:40 IL7.4 An update on PHACE syndrome - Dawn Siegel (USA)
12:40 - 12:50 SP7.1 Molecular characterization and clinical correlation of Large and Giant Congenital Nevi: beyond NRAS mutations - Ms Jilliana Monnier (France/Spain)
13:00 - 13:45 Sponsored Symposium
13:50 – 14:50 Session 9 Skin Tumours and Tumour Syndromes
Chairs: Josep Malvehy (Spain) & Marc Lacour (Switzerland)
13:50 - 14:10 IL9.1 New and old sistemic therapy in skin tumours and tumour syndromes Darren Hargrave (UK)
14:10 - 14:25 IL9.2 What you should know about LCH Vasanta Nanduri (UK)
14:25 - 14:40 IL9.3 What you should know about simple and complex melanocytic tumours Josep Malvehy (Spain)
14:40 - 14:50 IL9.4 Chronic Cutaneous Graft Versus Host Disease in Children in the Era of Stem Cell Transfer - Arti Nanda (Kuwait)
WHITTLE AUDITORIUM
11:30 – 12:50 Session 8 Papulosquamous
Chairs: Eli Sprecher (Israel) & Ruth Murphy (UK)
11:30 – 11:50 IL8.1 Single gene disorders as disease models: the CARD14 story - Eli Sprecher (Israel)
11:50 – 12:10 IL8.2 The multiple clinico-pathologic faces of pityriasis lichenoides - Sylvie Fraitag (France)
12:10 – 12:25 IL8.3 Psoriasis in the adolescent - Lone Skov (Denmark)
12:25 – 12:40 IL8.4 Update on pediatric lichenoid dermatoses - Jon Dyer (USA)
12:40 – 12:50 SP8.1 Mid-face Toddler Excoriation Syndrome (MITES) can be caused by homozygous mutations in PRDM12 - Prof Celia Moss (UK)
13:00 – 13:45 Sponsored Symposium
13:50 - 14:50 Session 10 Hair and Nail Disorders
Chairs: Paul Farrant & Franck Boralevi (France)
13:50 – 14:10 IL10.1 A practical approach for clinicians on managing the child presenting with hair - Paul Farrant (UK)
14:10 – 14:25 IL10.2 Nail disorders in children not to be missed - Bertrand Richert (Belgium)
14:25 – 14:40 IL10.3 Alopecia, Hypotrichosis and uncombable hair syndrome: when to think about genetic testing - Regina Betz (Germany)
14:40 – 14:50 SP10.1 Hypohidrotic ectodermal dysplasia: Cure of sweating disability by prenatal therapy - Prof Holm Schneider (Germany)
15:00 – 15:35 Keynote Lecture 04 KL04 Genetic investigation of rare inherited and mosaic skin disorders reveals novel pathways for disease pathogenesis Keith Choate (USA)
Chairs: Eugene Healy (UK) & Debra Lomas (UK)
FLEMING AUDITORIUM
FLEMING AUDITORIUM
15:35 - 16:10 Coffee break, Posters, Exhibition
(Britten & Pickwick rooms)
16:10 - 17:30 Session 11 Atopic and Contact Dermatitis
Chairs: Alan Irvine (UK) & Sara Brown (UK)
16:10 - 16:30 IL11.1 Staph Aureus and AD: New Insights - Alan Irvine (UK)
16:30 - 16:50 IL11.2 What does genetics tell us about AD/atopy? - Sara Brown (UK)
16:50 - 17:05 IL11.3 New and Emerging Therapies in AD - Michael Cork (UK)
17:05 - 17:20 IL11.4 Contact Allergens in Childhood Atopic Dermatitis: An Update - Flora de Waard van der Spek (The Netherlands)
17:20 - 17:30 SP11.1 Early Atopic Dermatitis: Prevention study - Ms Gaelle Bellemere (France)
WHITTLE AUDITORIUM
15:35 – 16:10 Coffee break, Posters, Exhibition
(Britten & Pickwick rooms)
16:10 - 17:30 Session 12 Pigmentary Disorders
Chairs: Alain Taieb (France) & Linda de Raeve (Belgium)
16:10 - 16:30 IL12.1 Vitiligo in children: maximizing efficacy in management - Alain Taieb (France)
16:30 - 16:50 IL12.2 Spitzoid lesions in children: diagnosis and management - Elvira Moscarella (Italy)
16:50 - 17:05 IL12.3 Pigmented lesions in Neurofibromatosis type 1: not only café-au-lait macules - Angela Hernandez-Martin (Spain)
17:05 - 17:20 IL12.4 Acquired hyperpigmentation of the skin - Marcel Bekkenk (The Netherlands)
17:20 - 17:30 SP12.1 Segmental odonto-maxillary dysplasia is caused by mosaic variants in the gene encoding beta-actin - Dr Satyamaanasa Polubothu (UK)
17:30 – 18:15 ESPD General Assembly FLEMING AUDITORIUM
SATURDAY 9 JUNE 2018
FLEMING AUDITORIUM
09:00 - 10:00 Session 13 Case presentations
Chairs: Regina Folster-Holst (Germany) & Bert Callewaert (Belgium)
09:00 - 09:15 SP13.1 - SP13.3 Important Cases Regina Folster-Holst (Germany)
09:15 - 09:30 SP13.4 - SP13.6 Important Cases Bert Callewaert (Belgium)
09:30 - 09:35 SP13.7 Bronchiolitis Obliterans and severe Ocular disease as long-term sequelae of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: a case series of 3 children - Dr Ella Seccombe (UK)
09:35 - 09:40 SP13.8 The importance of the dermatologist in the early manifestations of APECED - Dr Ariane Schreiber (France)
09:40 - 09:45 SP13.9 A child diagnosed with Blau Syndrome - Mr Alexios Alexopoulos (Greece)
09:45 - 09:50 SP13.10 A Case Series of Three Patients with ANCA-associated Skin Disease in Childhood - Dr Mariana Noy (UK)
09:50 - 09:55 SP13.11 Diagnosis of complete deficiency of the sixth complement component in a young adults after a first invasive bacterial infection with cutaneous septic emboli - Dr Ariane Schreiber (France)
09:55 - 10:00 SP13.12 Hyperimmunoglobulinemia E syndrome as a cause of severe recalcitrant eczema and
resolution after bone marrow transplantation - Prof Ayse Deniz Yucelten (Turkey)
WHITTLE AUDITORIUM
09:00 - 10:00 Session 14 European Initiatives in Paediatric Dermatology
Chairs: Christine Bodemer (France) & Juan Ferrando (Spain)
09:00 - 09:20 IL14.1 ERN-Skin: The European Reference Network for rare, and undiagnosed skin disorders - Christine Bodemer (France)
09:20 - 09:40 IL14.2 EuroPEDRA - Daniel Hohl (Switzerland)
09:40 - 10:00 IL14.3 The ESPD Mentoring Scheme - Regula Waelchi (Switzerland)
10:10 – 10:45 Keynote Lecture 05 KL05 The Skin Manifestations of Auto-Inflammatory Diseases - Antonio Torrelo (Spain)
Chairs: Barbara Kunz (Germany) & Ernesto Bonifazi (Italy)
FLEMING AUDITORIUM
FLEMING AUDITORIUM
10:45 - 11:15 Coffee break, Posters, Exhibition
(Britten & Pickwick rooms)
11:15 - 12:35 Session 15 Hot Topics
Chairs: John Harper (UK) & Klara Martinaskova (Slovakia)
11:15 - 11:35 IL15.1 What’s hot: the year in review - John Harper (UK)
11:35 - 11:55 IL15.2 News about newborns - Peter Hoeger (Germany)
11:55 - 12:10 IL15.3 An update on gastrointestinal disease and the skin - Zsuzanna Szalai (Hungary)
12:10 - 12:25 IL15.4 What’s new in genetics and management of paediatric hair disorders - Ramon Grimalt (Spain)
12:25 - 12:35 SP15.1 Chronic Urticaria: A Spanish Pediatric Cohort - Dr Ana Martin-Santiago (Spain)
WHITTLE AUDITORIUM
10:45 – 11:15 Coffee break, Posters, Exhibition
(Britten & Pickwick rooms)
11:15 – 12:35 Session 16 Advances in Drug Therapy
Chairs: Carsten Flohr (UK) & Jan Izakovic (Switzerland)
11:15 – 11:35 IL16.1 Is there still a place for conventional systemic medication in AD in the biologic era? - Carsten Flohr (UK)
11:35 – 11:55 IL16.2 Novel therapeutic approaches in paediatric psoriasis - Amy Paller (US)
11:55 – 12:10 IL16.3 Sirolimus – a new weapon to tackle overgrowth and vascular anomalies - Eulalia Baselga (Spain)
12:10 – 12:25 IL16.4 Therapeutic innovation in common skin diseases - Maurice van Steensel (The Netherlands)
12:25 – 12:35 SP16.1 Safety and Efficacy of Low Dose Sirolimus in Patients with PIK3CA-Related
Overgrowth - Dr Pierre Vabres (France)
12:45 – 13:20 Keynote Lecture 06 KL06 Emerging Translational Therapies for Inherited Skin Fragility Disorders - Jemima Mellerio (UK)
Chairs: Susannah Hoey (UK) & Bisola Laguda (UK)
FLEMING AUDITORIUM
FLEMING AUDITORIUM
14:15 - 15:45 Session 17 Best cases
Chairs: Veronica Kinsler (UK) and Stephanie Christen-Zach (Switzerland)
Carlo Gelmetti (Italy)
Talia Kakourou (Greece)
Dirk Van Gysel (Belgium)
Celia Moss (UK)
Rudi Happle (Germany)
Official Language
All sessions will be in English.
